Lifevantage (NASDAQ:LFVN) Insider Kristen Cunningham Sells 8,901 Shares of Stock

Lifevantage Corporation (NASDAQ:LFVN) insider Kristen Cunningham sold 8,901 shares of Lifevantage stock in a transaction on Monday, September 14th. The stock was sold at an average price of $6.18, for a total transaction of $55,008.18. Following the completion of the transaction, the insider directly owned 120,162 shares in the company, valued at $742,601.16. This represents a 6.90% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Kristen Cunningham also recently made the following trade(s):

• On Friday, September 11th, Kristen Cunningham sold 100 shares of Lifevantage stock. The shares were sold at an average price of $6.41, for a total value of $641.00.

Lifevantage Trading Up 1.3%

Shares of LFVN opened at $6.25 on Tuesday. The firm has a market cap of $78.31 million, a PE ratio of 15.62 and a beta of 0.73. Lifevantage Corporation has a 12 month low of $3.90 and a 12 month high of $11.71. The stock has a fifty day moving average price of $6.41 and a 200-day moving average price of $5.95.

Lifevantage (NASDAQ:LFVN) last announced its earnings results on Thursday, August 27th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). Lifevantage had a return on equity of 21.56% and a net margin of 2.78%.The business had revenue of $42.38 million for the quarter, compared to analysts’ expectations of $44.00 million. As a group, research analysts forecast that Lifevantage Corporation will post 0.39 EPS for the current year.

Lifevantage Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be paid a dividend of $0.05 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.20 dividend on an annualized basis and a dividend yield of 3.2%. Lifevantage’s payout ratio is presently 50.00%.

Institutional Trading of Lifevantage

Several large investors have recently added to or reduced their stakes in the company. Engineers Gate Manager LP raised its stake in shares of Lifevantage by 109.7% in the second quarter. Engineers Gate Manager LP now owns 27,009 shares of the company’s stock worth $169,000 after purchasing an additional 14,131 shares during the last quarter. Bank of New York Mellon Corp boosted its position in Lifevantage by 11.9% in the first quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company’s stock valued at $145,000 after buying an additional 3,571 shares during the last quarter. Bank of America Corp DE boosted its position in Lifevantage by 24.3% in the first quarter. Bank of America Corp DE now owns 23,445 shares of the company’s stock valued at $101,000 after buying an additional 4,586 shares during the last quarter. Aristides Capital LLC acquired a new position in Lifevantage in the 4th quarter worth approximately $76,000. Finally, Hsbc Holdings PLC purchased a new position in Lifevantage during the 1st quarter worth approximately $51,000. Hedge funds and other institutional investors own 35.32% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Lake Street Capital increased their price objective on shares of Lifevantage from $5.00 to $6.00 and gave the company a “hold” rating in a research report on Friday, August 28th. Weiss Ratings reissued a “hold (c)” rating on shares of Lifevantage in a research report on Friday, August 21st. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $5.50.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.